Cumulatively, the data suggest that RIPK1 is emerging as a master switch that controls inflammation and cell survival in atherosclerosis progression, and phosphorylation of RIPK1, RIPK3 and MLKL are definitive indicators of necroptosis activation. Here, MLKL is linked to atherosclerosis.